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Tubulointerstitial responses in the progression of glomerular diseases:
Albuminuria modulates aj35 integrin. Proteinuria represents one of the
most unfavorable prognostic factors in the progression of nephropathies.
Several lines of evidence support a role for proteinuria per se in the
development of interstitial fibrosis, albeit the molecular mechanisms are
still unknown. We investigated the potential role of integrins expressed on
tubular cells in regulating the synthesis and organization of interstitial
matrix or as mediators of tubulointerstitial damage in conditions mimick-
ing the nephrotic milieu. Under basal conditions, cultured tubular cells
highly expressed 0313 and, at focal contacts, 0v133. In contrast, Ov/35 was
weakly and diffusely distributed all over the plasma membrane. Cultures
on a variety of matrix substrates (fibronectin, laminin, collagen types I and
IV, vitronectin, von Willebrand factor, fibrinogen) did not induce any
phenotypic change in integrin expression by tubular cells. Conversely, the
addition of albumin resulted in a highly increased membrane expression of
13, which was organized in typical focal contacts and was related to the
dose of albumin added. Immunofluorescence, flow cytometry, immuno-
precipitation and RT-PCR experiments argue for a complex mechanism
that includes increased post-transcriptionally regulated protein synthesis,
accelerated conversion of precursors to mature forms, and increased
surface delivery to discrete adhesive structures. Up-regulation of the 13
chain in tubular cells was confirmed in 9 out of 11 kidney biopsies from
proteinuric glomerulonephritides including membranous and focal scle-
rosing glomerulonephritis, while it was not expressed in nonproteinuric
kidneys including five biopsy specimens. This is the first report indicating
that proteinuria up-regulates the surface expression and distribution of a
specific integrin chain on tubular cells. These observations suggest the
participation of integrins in a hitherto unexplored mechanism of tuhulo-
interstitial responses to glomerular injury.
Clinical [1—6] and experimental [7—9] evidence suggests that the
progressive functional failure occurring in chronic renal diseases
mostly depends on tubulointerstitial damage. Events with differ-
ent pathogenesis lead to similar histopathological lesions, that is,
the constant presence of tubular atrophy, mononuclear cell infil-
trate and interstitial sclerosis in the advanced phases of all
nephropathies. This fact suggests that multiple stimuli converge
upon the interstitium through common final mechanisms [re-
viewed in 10—13]. Of particular interest is the evolution of some
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types of glomerulonephritis toward tubular atrophy and intersti-
tial sclerosis, occurring when the primary process involving the
glomerulus has already resolved. Indeed, recent studies have
shown that even the early phases of glomerular diseases are
associated with tubular damage, as evidenced by the increased
number of proliferating tubular cells [14]. In the last few years,
interest on the mechanisms of chronic renal failure has shifted
from glomerular to tubular cells [15], which can on the one hand
be damaged by several mediators, and on the other trigger the
release of potent factors that in turn lead to pathogenic interstitial
phenomena.
A complex network of intercellular signals originating from
glomerular cells, vascular endothelium, tubular and infiltrating
inflammatory cells is envisioned to control the adaptation to renal
injury. However, the biochemical basis of this communication
network remains elusive. Tubular epithelial cells respond to
different perturbations, including high glucose, TNF and LPS,
cytokines, such as IL-i, MCP-1, IL-6, TNF-n, TGF-j3 (endowed
with both chemoattractive and fibrogenic properties), and vaso-
active substances such as angiotensin II, endothelin and nitric
oxide [15, 161. Upon activation by such stimuli, tubular cells may
express molecules involved in the immune response such as MHC
class I and II and ICAM-1 [17, 181. Moreover, tubular cells
regulate the synthesis and deposition of basement membrane and
interstitial matrix components such as laminins, collagens and
fibronectin. The contact between tubular cells and interstitial
matrix is operated by specialized adhesion molecules, chiefly,
integrins.
Integrins are cs//3 transmembrane heterodimers derived from
multiple combinations of 15 a and 8 /3 chains [19, 201. Integrins
mediate adhesion of the basal surface of cells to the underlying
substratum by recognizing extracellular matrix components and by
interacting with different cytoskeletal molecules. At least during
the adhesion processes in vitro, they cluster in specialized struc-
tures called focal contacts.
Integrin expression can be regulated, among other factors, by
cytokines and antiadhesive proteins [21]. Moreover, some cyto-
kines, including TGF-[3, directly influence mRNA transcription of
integrins [22], or modulate interstitial matrix synthesis and con-
sequent rearrangement of integrins at focal contacts [23]. Accord-
ingly, matrix proteins can modulate integrin expression and, by
means of integrin-generated intracellular signals, regulate the
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synthesis, degradation, composition and organization of the ma-
trix itself [24]. Taken together, these findings argue for a major
role of integrins in the chain of events converging to the intersti-
tium and responsible for the changes leading to sclerosis.
Tubular damage can derive from the actions of several media-
tors that are in turn generated by tubular cells in response to high
grade proteinuria [25]. Both in clinical observations [26] and in
experimental models [27—29], proteinuria represents one of the
most unfavorable prognostic factors to scierogenesis. Decreased
proteinuria following pharmacological or dietetic therapy is asso-
ciated with less tubulointerstitial impairment [30—33].
The aim of this study was to investigate the potential role of
integrins in the transmission of tubulointerstitial messages, start-
ing from the novel hypothesis that integrin expression in renal
tubular cells can be modulated by molecules filtered during
proteinuria. To this purpose we evaluated the in vitro responses
elicited from tubular cells by several physiological and abnormal
matrix components and by nephrotic range proteinuria. We also
assessed the modifications of in vivo integrin expression during
nephrotic syndrome by evaluating a set of human biopsy samples
from either protcinuric or non-protcinuric patients.
Methods
Antibodies
The primary monoclonal antibodies (mAb) used in this study,
and the investigators who provided them, are as follows (Table 1):
MAR4, specific for (31, and MAR6, anti-6 integrin, from S.
Ménard (Istituto Nazionale Tumori, Milano, Italy); F2, anti-a3
integrin, and IST4, anti-fibronectin, from L. Zardi (Istituto per lo
Studio e Cura dci Tumori, Genova, Italy); AA3, specific for (34
integrin, from V. Quaranta (Scripps Research Institute, La Jolla,
CA, USA); 1A9 antibody to [35 integrin from M. Hemler and
R. Pasqualini (Dana Farber Cancer Institute, Boston, MA, USA);
CB43 antibody to the Na + /Ca2 pump [34], from F. Malavasi
(University of Ancona, Italy) and a mAb to coagulation factor
VIII from F. Bussolino (University of Torino, Italy). MAb SAM-I
to cr5 and Gi9 to cr2 integrins were purchased from Immunotech
(Marseille, France). MAb VIN11.5 to vinculin was from Sigma
Chemical Co. (St. Louis, MO, USA). Anti-pan-cytokeratins Mabs
were from Progen Biotechnik (Heidelberg, Germany) and Im-
mustain EURO/DPC (Liarberis, UK). Anti-human albumin was
from Dakopatts (Copenhagen, Denmark). For immunoperoxi-
dase staining and immunofluorescence techniques, mAbs were
used at a final Ig concentration of 10 to 40 tg/ml according to our
previous experience; immunoprecipitations were performed with
4 jxg mAb per sample. For control purposes, irrelevant antibodies
were routinely used.
Cell cultures
Human tubular cells were isolated from cortical fragments
obtained, with the patients' consent, from the normal part of
kidneys surgically removed for renal carcinoma. The fragments
were minced and passed through sieves of different pore size. The
cell suspension obtained was washed and seeded on culture plates
(Becton Dickinson, Lincoln Park, NJ, USA) containing RPMI
1640 medium (Sigma) supplemented with 20% fetal bovine serum
(Sigma), 2 mrvi glutamine (Sigma), 50 U/mI penicillin, and 50
.cg/m1 streptomycin (Sigma). Cells were cultured in a humidified
atmosphere with 5% CO2 at 37°C.
Cells were subcultured five times before use, and purity was
assessed by positive staining with mAb CB43 to the Na7Ca2°
pump, negative staining for coagulation factor VIII and positive
staining with a panel of anti-cytokeratin antibodies.
Immunofluorescence
After detachment with 0.05% trypsin-0.02% EDTA (Sigma),
5 x iO cells were plated onto 1.4 cm2 round glass coverslips in
24-well plates (Costar Corp., Cambridge, MA, USA). Cells were
incubated for eight hours in complete medium. After removal of
the medium and several washes in PBS, coverslip-attached cells
were fixed for 10 minutes at room temperature in 3% formalde-
hyde (from paraformaldehyde) in PBS, pH 7.6, containing 2%
sucrose. After rinsing in PBS, cells were permeabilized by soaking
the coverslips for three to five minutes at 20°C in HEPES-Triton
X-100 buffer (20 m'vi HEPES, pH 7.4, 300 m sucrose, 50 mM
NaCI, 3 msi MgCl2, and 0.5% Triton X-100).
Indirect immunofluorescence was performed as previously re-
ported [35, 36]. Briefly, the primary Ab was layered onto fixed and
permeabilized cells and incubated in a humid chamber for 30
minutes at 37°C. After rinsing in PBS-0.2% BSA, coverslips were
incubated with the appropriate rhodaminc-tagged secondary an-
tibody (Dakopatts) for 30 minutes at 37°C in the presence of 2
xg/ml of fluorescein-labeled phalloidin (Sigma). Coverslips were
mounted in Mowiol (Hoechst AG, Frankfurt/Main, Germany)
and observed in a Zeiss Axiophot photomicroscope equipped with
epifluorescence illumination and with planapochromatic oil im-
mersion lenses. Fluorescence images were recorded on Kodak
T-Max 400 film, exposed at 1000 ISO and developed in T-Max
Developer for 10 minutes at 20°C. Five experiments were per-
formed for each condition.
Indirect immunoperoxidase technique
Samples from 18 needle or surgical renal biopsies were snap-
frozen in isopentane pre-cooled in liquid nitrogen, and embedded
Table 1. Monoclonal antibodies employed in this study
Clone Specificity Provider
MAR4
MAR6
F2
IST4
AM
1A9
CB43
Anti-VIlI
SAM-i
Gi9
VIN 11.5
Pancytokeratin
Pancytokeratin
Anti-albumin
a5
a2
vinculin
Pancytokeratin
Pancytokeratin
human albumin
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in OCT 4583 (Miles Scientific, Naperville, IL, USA), and sec-
tioned (4 to 6 jxm) in a Reichert-Jung cryomicrotome. Uninvolved
areas of tumor nephrectomy specimens were used as normal
controls.
After air drying, cryostat sections were fixed in cold acetone and
washed in PBS. Slides were then placed in a solution of H2O2 in
methanol to quench endogenous peroxidase, washed in PBS and
blocked with a PBS solution containing normal serum from
rabbits (the host of the secondary antibody) and 0.01% avidin.
Following another wash, sections were incubated in 0.005% biotin
in PBS, washed again and then overlaid with 10 ig/ml primary
antibody for thirty minutes in a moisture chamber at room
temperature. Slides were rinsed in PBS, incubated for thirty
minutes at room temperature with biotinylated rabbit anti-mouse
IgG, rinsed again and incubated in avidin-biotin peroxidase
complex (Vector Laboratories Inc., Burlingame, CA, USA). Fi-
nally, slides were developed for 5 to 10 minutes with a solution of
0.075% diaminobenzidine and 0.015% H2O2 in 0.05 M Tris.
Sections were counterstained with Mayer's hematoxylin (Zymed,
San Francisco, CA, USA) and mounted in Clearium (Surgipath,
Canada) and examined with a Zeiss Axiophot photomicroscope
equipped with 16X and 63x planapochromatic lenses. To control
for specificity of the immunoperoxidase staining, parallel sections
of some randomly selected biopsies were overlaid with murine
monoclonal IgG antibody specific for Ewing's sarcoma cells
(Signet Laboratories, Dedham, MA, USA) as a primary antibody,
instead of the monoclonal anti-5 integrin antibody.
Flow cytometly
Cells were detached in 1 mi EDTA, washed in PBS and
incubated with the appropriate primary Ab at 4°C for 30 minutes.
After two washes in PBS, cells were treated with fluorescein-
labeled rabbit anti-mouse IgG (Dakopatts) for 30 minutes at 4°C,
rinsed in PBS, and analyzed using an EPICS XL counter (Coulter,
Hialeah, FL, USA) set to analyze 5,000 cells per sample. Data
were elaborated by the Immuno-4 program (Coulter). Each
antibody was assayed 4 to 6 times for each condition.
Metabolic labeling and extraction
A subconfluent tubular epithelial cell monolayer in a 75 cm2
flask was washed twice with methionine- and cysteine-free me-
dium (Sigma) supplemented with 5% dialyzed fetal bovine serum,
glutamine and antibiotics, and cultured for three hours in the
same medium. This medium was then removed and replaced by 4
ml of the same medium supplemented with 100 JLCi/ml 35S-
Translabel (Amersham Corp., Arlington Heights, IL, USA). After
an overnight incubation in the radioactive medium, cells were
washed three times with ice-cold PBS and extracted in 1 ml of 0.15
M NaCI, 50 ifiM Tris-HCI, pH 8.5, containing 1% sodium deoxy-
cholate, 1% Triton X-100, 2 mvi PMSF (phenylmethylsuiphonyl
fluoride), leupeptin (50 xg/ml), pepstatin (5 mg/mI) and aprotinin
(20 U/mi). Extracts were centrifuged for 30 minutes at 15,000 g at
4°C, and supernatants were used for immunoprecipitations.
Immunoprecipitation
Immunoprecipitation experiments were performed as previ-
ously described [37]. Briefly, radiolabeled lysates were precleared
with protein A-Sepharose CL-4B (Pharmacia LKB Biotechnology
Inc., Uppsala, Sweden) pre-coated with normal mouse serum
(Sigma). Precleared lysates were incubated with various selected
mAbs, and immunocomplexes were collected by protein A-
Sepharose CL-4B coupled with rabbit anti-mouse IgG (Pierce,
Rockford, IL, USA) used to maximize capture of mAb. After
several washes with extraction buffer, the final pellet was boiled in
Laemmli buffer [381 without /3-mercaptoethanol. Proteins in SDS
were separated on 8% polyacrylamide gels by electrophoresis.
Resultant gels were fixed, incubated in scintillation fluid, dried,
and exposed to Amersham Hyperfilm with intensifying screens at
—80°C for three days. Protein size was estimated using a series of
markers including myosin (200 kDa), phosphorylase b (92.5 kDa),
bovine serum albumin (69 kDa), egg albumin (46 kDa), and
carbonic anhydrase (30 kDa) that had been prelabeled by 14C
methylation (Amersham Co.). Five single experiments were per-
formed.
Cell treatments: Attachment to substrates
Round coverslips were coated for eight hours at 37°C with the
following substrates: fibronectin, laminin, collagens type I and IV,
gelatin (all from Sigma); vitronectin (from pooled normal human
sera); von Willebrand factor (provided by A. Federici, University
of Milano, Italy) or fibrinogen (donated by F. Bussolino, Univer-
sity of Torino, Italy) all at a concentration of 10 jxg/ml in PBS.
Cells were then plated and allowed to adhere for 4 or 18 hours at
37°C. At the end of the incubation, cells were fixed and processed
for immunofluorescence as described above.
Incubation with albumin, IgG and lipopolysaccharide (LPS)
For immunofluorescence, 5 X i0 cells were allowed to adhere
to round coverslips for eight hours at 37°C. Then the medium was
substituted with complete medium with one of three additions: (a)
human albumin (Human Albumin, Biagini, Pisa, Italy), starting
from a final concentration of 35 mg/mI and going down to 10, 2,
1, 0.5, 0.2 mg/mI; (b) human albumin at 35 mg/mI plus human IgG
(with intact Fe fragment) purified by alcoholic Cohn fractionation
(Endobulin, Immuno, Pisa, Italy) at a final concentration of 15
mglml); or (c) LPS (Sigma) at a final concentration of 50 pg/mI.
After a 5 or 20 hour incubation at 37°C in a humidified 5% CO2
atmosphere, cells were fixed and immunofluorescence performed
as described. To assess tubular epithelial cell function retention in
culture, for the same conditions as above we performed a staining
with the anti-human albumin antibody, to evaluate the in vitro
uptake of albumin. For immunoprecipitation, one 75 cm2 flask for
each condition described above was prepared and incubated for
five hours at 37°C in the CO2 incubator. Metabolic labeling and
immunoprecipitation were carried out as described at the appro-
priate time of incubation.
For flow cytometry analysis, one 75 cm2 flask was used for each
dilution of either human albumin or fatty acid-free bovine albu-
min (FAF-albumin, Sigma) starting from: (a) a final concentration
of 35 mg/mi; (b) 2 mg/mI; (c) 1.5 mg/mi; (d) I mg/mi; (e) 0.5
mg/mi; down to (f) 0.02 mg/ml. Human IgG was added to each
dilution to a final concentration of 15 mg/ml. Complete medium
was used as a control. Flasks were incubated for five hours at
37°C, Cells were then detached, fixed, labeled with the antibodies
and analyzed as described.
RNA extraction and reverse transcription-polymerase chain
reaction (RT-PCR)
After incubation in 1 mrvi EDTA for five minutes at 37°C, cells
were recovered and resuspended in RNAzol (Cinna Biotecx
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Fig. 2. Immunofluorescence staining of vinculin-containing fbcal contacts
in human cultured tubular cells. A large number of vinculin-containing
streaks were located at the endings of microfilament bundles at the
substrate-attachment surface of cells. Original magnification, x63 (N = 6
independent experiments).
Fig. 1. Immunofluorescence staining of human cultured tubular cells. The
cells were stained with mouse mAbs to Oi (A) or 13 (B) integrins followed
by incubation with the appropriate rhodam inc-tagged secondary antibody.
Both integrin chains were found in streaks at the endings of microfilament
bundles, strictly colocalizing with vinculin at structures corresponding to
focal contacts (see Fig. 2). Original magnification, x63. Figures are
representative of 6 independent experiments, each with comparable
results.
Laboratories Inc., Houston, TX, USA) in a proportion of 0.2 ml
for 106 cells. RNA was then extracted following the manufactur-
er's instructions. Briefly, after addition of 1/10 volume of chloro-
form, the suspension was vortexed and incubated at 4°C for 15
minutes. After centrifugation at 12,000 X g at 4°C for 20 minutes,
the supernatant was extracted with an equal volume of isopropa-
no!, incubated at —20°C for 45 minutes and re-centrifuged at
12,000 X g at 4°C for 20 minutes. The supernatant was then
discarded and the pellet precipitated twice in 75% ethanol and
centrifuged at 12,000 X g at 4°C for 15 minutes. The dried pellet
was finally resuspended in distilled water and considered as total
RNA. RNA yield and protein contamination were quantified by
UV absorbance at 260 and 280 nm.
For RT-PCR, I xg of total RNA was reverse transcribed and
then amplified by the polymerase chain reaction. Briefly, RNA
was mixed with 2.5 m random hexamers in 5 mvi MgCl2, 25 mM
KCI, 10 mi Tris-HCI, pH 8.3, and 1 mvi of each dNTP, and 2.5
U/mI Moloney murine leukemia virus reverse transcriptase (Per-
kin-Elmer-Cetus, Norwalk, CT, USA) in a final volume of 20 j.d.
Reverse transcription was carried out at 42°C for 15 minutes. This
reaction was then amplified by bringing each sample to a final
volume of 100 p1 with 2 mtvi MgCI2, 50 mM KCI, 10 mM Tris-HCI,
pH 8.3, 2.5 U Taq DNA polymerase (Perkin-Emler Cetus), and
0.15 M of the specific primer, in separate incubations. The
following reaction temperatures were used for each cycle: dena-
turation for one minute at 95°C, annealing for 1.5 minutes at 55°C,
and extension for 1.5 minutes at 72°C. Primers were: for the /35
integrin subunit:
forward 5'-CAGGATGGGGAGAACCAGAGC-3'
and reverse 5 '-CTGGTCATCTTFCACGATGGT-3';
for /3-actin, used as control,
forward 5'-CCTTCCTGGGCATGGAGTCCTG-3'
and reverse 5 '-GGAGCAATGATC1ITGATCITC-3'
The PCR reaction was performed semiquantitatively, that is, it
was stopped at 5, 12, 18 and 25 cycles and a dilution series of the
resultant DNA was performed before the final PCR amplification
was run. This procedure avoided saturation and a plateau effect in
the strongest signal. All the eDNA sample concentrations were
furthermore normalized to the housekeeping gene J3-actin. Ali-
quots of each reaction at different cycles were run on 2% agarose
gels, visualized with ethidium bromide,under UV illumination,
and the band intensities quantified by densitometry.
Results
Inlegrin expression in cultured renal tubular cells
To characterize the integrin expression pattern in primary
cultures of renal tubular cells under normal conditions, we used a
combined approach including immunocytochemistry, flow cytom-
etry analysis and immunoprecipitation.
Cultured tubular cells expressed a (Fig. IA), /3k, a and [3
chains (Fig. IB). All these chains of integrins were abundantly
distributed on the whole basal tubular cell surface along the
endings of microfilament bundles together with vinculin (Fig. 2)
and talin (not shown), indicating that these integrins are mainly
organized in focal contacts. The p chain was weakly and diffusely
distributed all over the plasma membrane (see below). No appre-
ciable staining for a, 05 a or /3 could be observed.
Data were confirmed by flow cytometty analysis of suspended
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Fig. 3. Immunoprecipitation of integrins.
Detergent lysates of metabolically labeled
tubular cells were immunoprecipitated with
control pre-immune mouse serum or the
indicated mAbs as described in the Methods
section. The eluates were analyzed by SDS-8%
PAGE under non-reducing conditions. Either
a3 or 13 specific mAbs immunoprecipitated
multiple bands corresponding to a3 and /3
mature subunits (respectively 150 and 110 kDa)
and precursors (140 and 95 kDa). A veiy faint
150 to 110 kDa doublet, corresponding
respectively to a. and f3, was brought down by
anti-a5 mAb. No chains were precipitated by
anti-a2 or a6 mAbs. Anti-133 mAb yielded two
broad bands representing a, (150 kDa) and f33
(95 kDa) (N = 4 independent experiments).
cells and by immunoprecipitation of radiolabeled lysates under
non-reducing conditions. Both a3 and I3 antibodies immunopre-
cipitated multiple bands (Fig. 3) corresponding to 03 and
mature subunits (respectively 150 and 110 kDa) and their precur-
sors (140 and 95 kDa). A very faint 150 to 110 kDa doublet was
brought down by anti-a5 antibodies. The absence of appreciable
expression of 05 by immunofluorescence methods and its detec-
tion by immunoprecipitation from metabolically labeled cells has
already been observed in primary cultures of human epidermal
keratinocytes, and is supposed to be due to lack of association of
this heterodimer to definite adhesive structures [39]. 02 and a,
mAbs failed to precipitate any integrin subunit, confirming the
immunofluorescence data.
The a integrin subunit was found to associate with both /33 and
f3 subunits. Immunoprecipitation with an anti-/33 mAb (Fig. 3)
yielded two broad bands at 150 and 95 kDa, whereas in anti-/35
immunoprecipitates (Fig. 4), three faint 150, 130 and 100 kDa
bands were observed, the 130 kDa band presumably representing
the cc, precursor [391. Recovery of the a precursor was obtained
following immunoprecipitation with a /35-specific mAb and not
with a /33-specific mAb, possibly indicating the presence of a
cytoplasmic pool of immature aj35 heterodimers preformed and
stored in endoplasmic reticulum vesicles, but neither exposed at
the cell surface nor organized in specialized adhesive structures
[39].
Integrin expression in renal tubular cells cultured on different
matrix substrates
To evaluate whether the presence of isolated extracellular
matrix proteins could influence the integrin expression pattern or
cell shape and adhesive properties, cells were plated onto selected
substrates contained within the interstitium under physiological
conditions (laminin, types I and IV collagen, fibronectin or
vitronectin) or possibly present under pathological conditions
such as inflammation or sclerosis (fibrinogen, denatured type I
collagen, von Willebrand factor). Cells were then incubated for 4
or 18 hours, fixed and processed for immunofluorescence. The
two time points selected were chosen according to time-course
experiments, from 0 to 24 hours performed both on tubular cells
and on other cell types, such as mesangial cells, keratinocytes and
endothelium [22, 40, 41], demonstrating that integrin expression
modifications were extremely rapid events, mostly happening
within one hour and then remaining stable for a plateau. Under
no circumstances did cells change their phenotype or integrin
pattern in the two points considered, which were chosen to be able
to catch early and eventual late events.
Integrin expression in renal tubular cells under conditions mim-
icking nephrotic syndrome. To evaluate the possible modulatory
effect of molecules filtered to the pre-urine under conditions of
altered glomerular permselectivity, we simulated a nephrotic
proteinuria in the extreme case, assuming maximal derangement
of the glomerular barrier, at an albumin concentration equal to
that of plasma. Under these conditions, the most striking result
was related to changes in the synthesis, surface expression, and
cytoskeletal association of the aj35 integrin. As already men-
tioned, in renal tubular cells in basal conditions aj35 is poorly
expressed and diffusely distributed on the basal plasma mem-
brane, and is not organized in defined adhesive structures (Fig.
5A). In contrast, cells stimulated by albumin showed a clear ccf3
staining that was organized in typical focal contacts (Fig. SB). The
same conversion to sharp focal positivity was obtained after
incubation with albumin and TgG (Fig. 5C) and with the non-
specific stimulatory agent LPS (Fig. SD), while no modification
was induced by using IgG alone (data not shown). LPS was
included in the experiment as a positive control due to its capacity
to induce strong cellular perturbations and activation in most cell
populations binding to different cellular receptors [42] and acting
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Fig. 4. Immunoprecipitation of integrins from metabolically labeled deter-
gent extracts. Under basal conditions, anti-f3 mAb immunoprecipitated
three bands corresponding to f3 (100 kDa), (150 kDa) and presumably
an a, precursor (130 kDa). The band intensity increased in cells incubated
in the presence of albumin (Aib) or co-stimulated by albumin and IgG
(Alb + IgG), and peaked after LPS treatment. Little or no a precursor
was precipitated in treated cells (N = 3 separate experiments).
through the activation of the NFKB factor [43]. LPS was previ-
ously demonstrated to induce several tubular events including the
synthesis of TNF-a [44], the inducible form of nitric oxide
synthase [45] and the interferon-inducible protein-lO [46].
The capacity to retain the cellular functions of in situ tubular
cells was assessed by evaluating the cytoplasmic uptake of human
albumin, which appeared to be conserved as displayed by the
dense granular intracytoplasmic positivity by means of immuno-
fluorescence (Fig. 6).
To investigate the synthesis and assembly of the receptor as well
as its ratio of membrane exposure, we respectively immunopre-
cipitated metabolically labeled lysates and analyzed stimulated
cells by flow cytometry. In anti-[35 immunoprecipitates, two broad
150 and 100 kDa bands could be observed (Fig. 4). The band
intensity increased in cells co-stimulated by albumin and IgGs and
peaked after LPS treatment. No a precursor, precipitated from
control cells, was precipitated in treated cells.
Similarly, flow cytometry analysis revealed that under basal
conditions, 40 to 50% of the tubular cells expressed 135 very faintly.
In contrast, an increased surface positivity according to a linear
dose-response curve was observed in treated cells over a range of
concentrations of albumin, from the maximal 35 mg/mI to the 0.2
mg/mI level, similarly to the albumin concentration in the proxi-
mal tubule of rats with experimental puromycin nephrosis, and
0.02 mg/ml, the concentration of albumin physiologically present
in the glomerular filtrate, from micropuncture data [47, 48]. The
flow cytometry experiments were aimed at better analyzing the
low concentrations of albumin, the effects of which were difficult
to discriminate under the immunofluorescence microscope. These
experiments showed that albumin induced an increase in 135
expression starting from the 0.2 mg/mI concentration (64.3% of
positive cells, with a mean fluorescence intensity of 1.74, com-
pared to the 48.8% positive cells in basal conditions with 1.45
mean fluorescence intensity), at the 0.5 mg/mI albumin concen-
tration (74.4% of positive cells, mean fluorescence intensity 1.81)
and at 2.0 mg/mI (87.2% of positive cells, mean fluorescence
intensity 2.1; Fig. 7).
The 35 mg/mI albumin concentration induced an even more
intense effect in immunofluorescence, however, under flow-cy-
tometry analysis albumin concentrations over 10 mg/mi were not
able to induce distinguishable dose/response effects, as if the
maximal activation was already obtained (data not shown).
Lipid-free bovine albumin failed to induce any modification of
f3 expression at each of the concentrations assayed. IgG alone did
not cause any effect.
To elucidate the mechanisms regulating 13 synthesis, we tried a
semiquantitative RT-PCR approach on cells incubated under the
same conditions used for flow cytometry analysis. In both un-
treated and treated cells, a specific 510 bp amplification product
was present with band densities parallel to those of the house-
keeper gene /3-actin. Expresssion levels were almost identical in
all samples. By stopping the reaction after different numbers of
cycles, uniform levels of the transcript were achieved with kinetics
analogous to the internal [3-actin standard (Fig. 8). Thus, steady
state mRNA levels do not appear to be affected by stimuli that
increase immunoprecipitable protein levels.
Taken together, these data argue for a finely tuned regulation
of a135, possibly involving a post-transcriptionally-regulated in-
crease of protein synthesis, accelerated conversion of precursor
heterodimers to mature forms, and/or increased delivery to the
cell surface, where the integrin clusters at discrete adhesive
structures.
Integrin expression in renal sections in situ
Eleven of the patients we studied were subjected to renal biopsy
to assess heavy proteinuria of presumed glomerular origin: four
had 1gM nephropathy, three had focal glomerulosclerosis, three
had focal proliferative endocapillary glomerulonephritis without
necrosis (1 each with post-infectious, systemic lupus or Henoch-
Schonlein glomerulonephritis), and one proved to have membra-
nous nephropathy upon renal biopsy. Among these patients, nine
(82%) revealed strong immunoperoxidase staining for [3integrin
chain on the surface of cells in some cortical tubules (Fig. 9A). On
average, one third of the cortical tubular cross-sections exhibited
the same quality (positive or negative) and intensity of staining. In
contrast, five of the six patients without proteinuria in excess of 1.5
g/day had no [3 integrin chain detectable in cortical tubules by
immunoperoxidase (Fig. 9B). The one patient who did have
moderate staining for 13 integrin in 20% of his cortical tubular
cross-sections was diagnosed with chronic tubular degeneration
secondary to drug toxicicty, and in fact revealed extensive injury in
the convoluted tubules. Staining for [3 integrin was therefore
significantly (P < 0.01) more frequent among patients with heavy
glomerular proteinuria than in patients with non-glomerular renal
disease and urinary proteinuria excretion below 1.5 g/day ( =
4.5). This staining is considered specific, because no staining was
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Fig. 5. Immunofluorescence staining of the 135
integrin chain in cultured human tubular cells.
Under basal conditions, OvPS was poorly
expressed and diffusely distributed on the basal
plasma membrane and was not organized in
defined adhesive structures (A). In contrast,
cells stimulated by albumin showed a clear a/3
staining, organized in typical focal contacts (B).
The same conversion to sharp focal positivity
was obtained after incubation with albumin and
IgG (C) and with the non-specific stimulatory
agent LPS (D).
Discussion
Fig. 6. Immunofluorescence staining of human cytoplasmic albumin,
expressing albumin uptake, after 4 hr incubation with human albumin (35
mg/mi final concentration), fixation, permeabilization and staining with an
anti human aibumin monoclonal antibody.
observed when an irrelevenat primary antibody (specific for
Ewing's sarcoma cells) was applied to parallel sections from four
of the biopsies that stained positively for 13 integrin.
The biopsy samples studied, even those displaying tubular 135
integrin expression did not show any significant interstitial fibro-
sis, neither in the areas sorrounding the positive tubules nor in
other compartments. This is possibly in accordance with the early
onset of these nephropathies.
Moreover, no staining for f3 integrin was present in any of the
sections obtained from the normal parts of kidneys removed for
carcinoma, which were the same kidneys used to establish the cell
lines fore the in vitro experiments described above.
Proteinuria apparently plays a key role in the development of
interstitial fibrosis [25, 28—30]. Increased protein traffic through
proximal tubular cells, activated to reabsorb and catabolize the
filtered proteins, may give rise to a metabolic derangement of
tubular epithelial cells, which in turn could affect the interstitium
[49]. Tubular cells are active elements able to participate in
phlogistic and immune processes by secreting cytokines, growth
factors, vasoactive substances [reviewed in 15, 50], and molecules
involved in antigen presentation and signal transduction [17, 51].
However, the specific mechanisms linking proteinuria to tubular
responses are still unclear.
Several filtered proteins can exert specific effects. For instance,
transferrin delivers iron ions to the intracellular acidic environ-
ment, where these ions catalyze the formation of reactive oxygen
species [521, thus damaging the apical membrane of tubular cells
and probably disturbing other cellular functions. Complement
proteins, filtered during massive proteinuria, can be activated on
the brush border of proximal tubular cells [53] with a consequent
insertion of the membrane attack complex onto the tubular cell
membrane [54], followed by profound cytoskeletal alterations,
cytolysis [55], and possibly synthesis of cytokines and autacoids.
Lipoproteins, filtered in the course of non-selective proteinuria,
are specifically bound by membrane receptors and recycled within
the cytoplasm, where they release the lipid moieties that can
accumulate into lipid droplets, or be oxidized to toxic radicals [56,
57]. Moreover, it is conceivable that some of the responses evoked
by LDL from mesangial cells, such as proliferation [58], expres-
sion of early nuclear genes and increased transcription of PDGF,
fibronectin and other matrix proteins [59, 60], could also he
elicited from tubular epithelial cells.
N
J 
-
 
-
S 
(fl 
U,
 
N
J 
C)
 
CD
 
'C
 
C)
 
'C
 
C)
 
'C
 
'C
 
C)
 
C'
 5 
"
 5 
a
 0 
& 0) 
(n 
In
 
0) 
Bl
an
k 
AI
b.
 3
.5
 g
Jd
l 
AI
b.
 2
00
 m
g/
dl
 
AI
b.
 2
0 
m
g/
dl
 
LP
S 
lg
G
 
N
on
 tr
ea
te
d 
AI
b.
 3
.5
 g
Id
l 
AI
b.
 2
00
 m
g/
dI
 
AI
b.
 2
0 
m
g/
dl
 
LP
S 
Ig
O
 
N
on
 tr
ea
te
d 
tt Na Ui o o a a 0 0 
Peruzzi et al: Albuminuria and integrin expression 1317
Fig. 7. Flow cytometly analysis of /35 chain
expression on tubular cells incubated with human
albumin The X axis shows fluorescence intensity;
the Y axis shows relative cell number. Human
albumin induced a strong increase of j3
expression, displayed by the right shift of the
peak on the fluorescence intensity log scale and
by the increase of the positive cells percentage,
expressed by the hight of the peak.
Fig. 8. Semiquantitative RT-PCR analysis of the
135 integrin transcript in cultured tubular cells
under different conditions. One microgram of the
total RNA from untreated or treated cells was
reverse transcribed and amplified with specific
/35 integrin oligonucleotides as well or with /3-
actin oligonucleotides as an internal control.
The reaction was stopped at 5, 12, 18 and 25
cycles. In both untreated and treated cells, a
specific 510 bp amplification product was
present, with band densities parallel to those of
the housekeeper gene /3-actin. The amplificands
were almost identical in all samples. For
reactions stopped after different numbers of
cycles, the transcript appeared to be wholly
analogous to the internal /3-actin standard.
bic substances including hormones, vitamins, lipids. Upon albu-
min uptake by tubular epithelial cells, these substances could he
released into the cytoplasm and be responsible for the effects
attributed to albumin, with a mechanism analogous to that
described for lipoproteins. It has been recently demonstrated [61]
that tubular cells incubated with albumin charged with lipids
release a lipid factor, endowed with macrophage chemotactic
activity, that has a chromatographic pattern identical to a lipid
factor extracted from urine of rats with experimental protein-
fore, the proximal tubule would metabolize large quantities of
albumin and lipids, and produce a novel lipid that is able to attract
macrophages to the interstitium. Lipid moieties carried by albu-
min have been shown to trigger many signal transduction path-
ways involving several effectors. One or more of these could
modulate interactions between cells and the extracellular matrix,
thus initiating a series of events potentially leading to monocyte!
macrophage recruitment and interstitial fibrogenesis.
Integrins represent a critical interface between cells and their
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Albumin physiologically carries different moieties of hydropho- overload proteinuria. In the case of massive proteinuria, there-
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Fig. 9. Immunoperoxidase staining of a nephrotic(a) and a normal (b) kidney section. In the
proteinuric condition, some cells, apparently in
proximal convoluted tubules, strongly expressed
the j3 integrin chain (a). Conversely, tubular
epithelium from normal kidney showed only a
weak positivity for the f35 subunit (b).
environment, including the extracellular matrix. In turn, integrins
may play a major role in the synthesis, degradation and compo-
sition of the extracellular matrix, as well as in transmembrane
signaling. Therefore, alterations in the expression and/or func-
tional status of integrins may represent, in whole or in part, a
metabolic connection between the contents of the tubular lumen
and interstitial fibrosis. In this paper, we analyzed the expression
of integrins by tubular cells in culture, and the modulation of
integrin expression by proteins filtered when glomerular perms-
eleetivity is lost. Under basal conditions, cultured tubular cells
mainly express a5f31 and rsvP3, at the cytolemma enriched at focal
contacts. The rs3f31 integrin is a promiscuous receptor that binds to
laminin, fibronectin, collagen type I and nidogen/entactin, while
aP3 may recognize a range of ligand sites on vitronectin, fibrin-
ogen, von Willebrand factor, thrombin and thrombospondin. In
contrast with reported data obtained from histological sections
[62, 63], immunofluorescence as well as immunoprecipitation and
flow cytometry analysis performed on cultured tubular cells could
not detect any expression of a6 chain. Conceivably, the loss of cell
polarity due to the disruption of the tubular structure and the
culture on plastic or glass induces changes in the panel of integrins
expressed by tubular cells.
The basal integrin expression pattern was not modified by
contact with physiological matrix components, such as laminin,
type IV collagen (present in the tubular basement membrane),
type I collagen (expressed in normal interstitium), fibronectin, or
vitronectin, nor by contact with substrates potentially present in
the matrix under pathological conditions, such as fibrinogen, von
Willebrand factor, or denatured type I collagen. Accordingly, no
changes in cell shape, cytoskeletal architecture or organization of
adhesive structures could be observed. Taken together, these data
suggest that, under our experimental conditions, modifications of
the matrix environment are not a perturhing factorperse. Rather,
any such changes might be an epiphenomenon of an early
pathogenetic event arising from components acting directly on the
tubular cell.
Consequently, we investigated the potential role of molecules
abnormally present in the tubular lumen in cases of severe
derangement of the glomerular ultrafiltration, that is, albumin and
lgG. From this point of view, tubulointerstitial progression of
glomerular disease would not depend on direct interstitial dam-
age, but rather would rely upon noxious lumenal elements acting
primarily on the tubule. Tubular cells might then respond to the
abnormal lumenal composition by remodeling their adhesive
apparatus, thereby exposing new provisional matrix receptors,
thence triggering "inside-out" signals that might progressively
convert the interstitium into a fibrotic tissue by activating fibro-
blasts and/or leukocytes.
The most striking modification of cultured tubular cells upon
albumin treatment was the augmented synthesis, at the protein
level, of a135, as well as its surface exposure at focal contacts. This
finding was validated by different techniques including immuno-
fluorescence, flow cytometry, immunoprecipitation and RT-PCR
analysis performed on cultured tubular cells, and further con-
firmed by the positive tubular staining with aI35 on renal sections
from 9 out of 11 heavily proteinuric patients. To our knowledge,
these results represent the first report of a selective alteration of
the integrin-based adhesive machinery in tubular cells that have
come into contact with concentrations of albumin similar to those
found in states of massive proteinuria. The retargeting of pre-
formed integrins to defined adhesive structures both in tissue
sections and in primary cultures has already been observed for
a5131 in psoriatic keratinocytes [22] and a comparable mechanism
exists for platelets [40, 41] and for the fast activation of a5/31 in
resting CD4+ human T cells [64]. Moreover, a new a-based
heterodimer (ap6) is specifically induced in conditions mimicking
wound healing in keratinocytes [22]. However, the induction of a
and the specific targeting of 135 to focal contacts in addition to 133
with resultant exposure of a new a-based heterodimer, cannot be
explained simply. The only interpretation we can offer is that the
signals derived from a in combination with distinct f3chains arc
different, and imply complex phenotypic changes. The whole
problem requires deeper investigation. Likewise, increased recov-
ery of biosynthetically labeled a135 integrin without altered steady
state mRNA levels warrants added investigation. Specifically, the
lipid content of albumin is implicated, since aP5was recruited to
focal contacts only by lipid-laden albumin, and not by albumin
stripped of lipids.
The function and the regulatory mechanisms of the alternative
vitronectin receptor a/35 are still under scrutiny, even though its
biochemical and molecular features have been established long
ago [65—67]. Ours, though, is the first finding of a molecule
expressed on tubular cells that can be modulated by albumin, or
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presumably by the lipid moieties carried by albumin. This modu-
lated integrin possibly behaves as a mediator between the tubular
lumen and the interstitium. Interestingly, this integrin can be
expressed in a partially active form and be converted to a
functionally active molecule by some still unidentified factors.
Therefore, the a,j35 heterodimer represents a potential conver-
gence of different stimuli.
In summary, this study demonstrates that proteinuria can
up-regulate the expression of a particular integrin that could
represent a central mediator in a network of tubulointerstitial
messages evoked by an increased protein load to tubular cells.
This event, if protracted, might activate a cascade of events
leading to tubular atrophy and interstitial fibrosis, and finally to
progressive impairment of renal function.
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